Acadia Healthcare Company, Inc.(ACHC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,260 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ACHC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Acadia Healthcare Company, Inc. (ACHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACHC at 36.7/100 on a 32-signal composite quality model, placing it at rank #2,260 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (11.5) and profitability (12.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Acadia Healthcare Company, Inc. reports quarterly revenue of $828.8M, net income of $4.1M, free cash flow of $-15.0M. Top institutional holders of ACHC by reported 13-F value include BlackRock, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ACHC trades on the Nasdaq exchange and files with the SEC under CIK 1520697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Acadia Healthcare Company, Inc. directly from SEC EDGAR. Acadia Healthcare Company, Inc.'s 13F Pro composite quality score has ranged between 32 and 63 since 2021, currently 36.7 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q1 2026
$828.8M
Net Income
Q1 2026
$4.1M
Free Cash Flow
Q1 2026
$-15.0M
ROIC
Q1 2026
1.0%
D/E Ratio
Q1 2026
1.31
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+5.0% YoYNet Income
-531.4% YoYEPS (Diluted)
-537.4% YoYTotal Assets
-7.2% YoYTotal Debt
+24.3% YoYOp. Cash Flow
+1.7% YoYFree Cash Flow
+21.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.31B +5.0% | $3.15B +7.7% | $2.93B +12.2% | $2.61B +12.8% | $2.31B +10.7% | $2.09B |
| Net Income | $-1.10B -531.4% | $255.6M +1279.7% | $-21.7M -107.9% | $273.1M +43.3% | $190.6M +128.4% | $-672.1M |
| EPS (Diluted) | $-12.16 -537.4% | $2.78 +1258.3% | $-0.24 -108.1% | $2.98 +41.9% | $2.10 +127.7% | $-7.59 |
| Total Assets | $5.53B -7.2% | $5.96B +11.2% | $5.36B +7.4% | $4.99B +4.6% | $4.77B -26.6% | $6.50B |
| Total Debt | $2.53B +24.3% | $2.03B +45.2% | $1.40B -0.4% | $1.41B -7.2% | $1.52B -53.7% | $3.28B |
| Operating Cash Flow | $131.9M +1.7% | $129.7M -71.9% | $462.3M +21.5% | $380.6M +1.6% | $374.5M -43.2% | $658.8M |
| Free Cash Flow | $-439.9M +21.5% | $-560.7M -1567.5% | $38.2M -54.7% | $84.4M -34.9% | $129.7M -70.1% | $433.8M |
Get alerted when ACHC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Acadia Healthcare Company, Inc. including:
Top Institutional Holders of ACHC
BlackRock, Inc.
$441.7M14,957,168 shWELLINGTON MANAGEMENT GROUP LLP
$169.1M5,726,246 shVANGUARD PORTFOLIO MANAGEMENT LLC
$158.6M5,369,461 shFMR LLC
$148.1M5,015,727 shCARRONADE CAPITAL MANAGEMENT, LP
$140.6M4,762,635 shMORGAN STANLEY
$133.9M4,534,269 shDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$133.5M4,520,000 shDME Capital Management, LP
$130.0M4,400,641 shFARALLON CAPITAL MANAGEMENT LLC
$124.6M4,220,800 shABRAMS BISON INVESTMENTS, LLC
$123.0M4,165,000 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $441.7M | 14,957,168 |
| WELLINGTON MANAGEMENT GROUP LLP | $169.1M | 5,726,246 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $158.6M | 5,369,461 |
| FMR LLC | $148.1M | 5,015,727 |
| CARRONADE CAPITAL MANAGEMENT, LP | $140.6M | 4,762,635 |
| MORGAN STANLEY | $133.9M | 4,534,269 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $133.5M | 4,520,000 |
| DME Capital Management, LP | $130.0M | 4,400,641 |
| FARALLON CAPITAL MANAGEMENT LLC | $124.6M | 4,220,800 |
| ABRAMS BISON INVESTMENTS, LLC | $123.0M | 4,165,000 |
Companies Similar to ACHC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Enovis CORP
AdaptHealth Corp.
Brookdale Senior Living Inc.
TELEFLEX INC
OLIN Corp
CENTENE CORP
SUPERNUS PHARMACEUTICALS, INC.
QuidelOrtho Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put ACHC on your watchlist
Track score changes the day Acadia Healthcare Company, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACHC a good stock to buy?
13F Pro's AI-powered analysis of Acadia Healthcare Company, Inc. (ACHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACHC are available on the ACHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ACHC is classified as a mid company.
Which hedge funds own ACHC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Acadia Healthcare Company, Inc.'s investment landscape.